CANSF

Header iconCANSF Comparison
Open Charts CANSFBanner chart's image
Willow Biosciences
Price$0.02
Change-$0.00 (-0.00%)
Volume$20K
Capitalization8.74M
CANSF Comparison Chart
Loading...
View a ticker or compare two or three
Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (CANSF: $0.02)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANSF’s FA Score shows that 0 FA rating(s) are green while.

  • CANSF’s FA Score: 0 green, 5 red.

Price Growth

CANSF (@Pharmaceuticals: Other) experienced а +15.61% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +65.85%. For the same industry, the average monthly price growth was -3.09%, and the average quarterly price growth was -1.31%.

Industries' Descriptions

@Pharmaceuticals: Other (+65.85% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
CANSF
Capitalization8.74M
EBITDA-10.02M
Gain YTD-41.481
P/E RatioN/A
Revenue1.59M
Total Cash3.68M
Total Debt1.66M
FUNDAMENTALS RATINGS
CANSF: Fundamental Ratings
CANSF
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IBSSX22.61N/A
N/A
VY® Baron Growth S
VTIAX34.29N/A
N/A
Vanguard Total Intl Stock Index Admiral
WILNX20.39N/A
N/A
William Blair International Ldrs N
BARUX95.73N/A
N/A
Baron Asset R6
SMNIX28.10N/A
N/A
Steward Equity Market Neutral I

CANSF and Stocks

Correlation & Price change

A.I.dvisor tells us that CANSF and LNTH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANSF and LNTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANSF
1D Price
Change %
CANSF100%
+12.86%
LNTH - CANSF
21%
Poorly correlated
+3.56%
VTRS - CANSF
21%
Poorly correlated
-0.31%
CANQF - CANSF
6%
Poorly correlated
N/A
CRLBF - CANSF
1%
Poorly correlated
-5.39%
BUDZ - CANSF
1%
Poorly correlated
-10.60%
More